Beyond LNB: Real life data on occurrence and extent of CSF CXCL13 in neuroinflammatory diseases

J Neuroimmunol. 2020 Jan 15:338:577087. doi: 10.1016/j.jneuroim.2019.577087. Epub 2019 Nov 2.

Abstract

To evaluate occurrence and extent of CSF CXCL13 elevations beyond Lyme neuroborreliosis, we investigated CXCL13 in an unselected patient cohort with neuroinflammatory disease. From March 2016 to March 2017, 180 in-patients with CSF pleocytosis were categorized into following groups: pyogenic CNS infections, aseptic meningoencephalitis, neuroimmunological diseases, and reactive pleocytosis. We provide evidence that CXCL13 elevation occurs at variable extent in the majority of neuroinflammatory diseases. The exact role of CXCL13 in CSF is elusive, but the broad occurrence in neuroinflammation points at CNS immune activation, which is not exclusive for LNB.

Keywords: CNS; CSF; CXCL13; Neuroinfection; Neuroinflammation.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Chemokine CXCL13 / cerebrospinal fluid*
  • Chemokine CXCL13 / physiology
  • Female
  • Humans
  • Leukocytosis / cerebrospinal fluid
  • Leukocytosis / immunology
  • Lyme Neuroborreliosis / cerebrospinal fluid*
  • Lyme Neuroborreliosis / immunology
  • Male
  • Meningoencephalitis / cerebrospinal fluid
  • Meningoencephalitis / immunology
  • Middle Aged
  • Young Adult

Substances

  • CXCL13 protein, human
  • Chemokine CXCL13